Benign Prostatic Hyperplasia Treatment Analysis With Industry Size, Scope, Demand and Competitive Outlook by 2025
The global benign prostatic hyperplasia treatment market grew at a CAGR of 8% during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth during 2020-2025. Benign prostatic hyperplasia (BPH) refers to non-cancerous growth of the prostate gland that causes urethra blockage. This disorder generally results in the retention of urine, formation of bladder stones, incontinence due to overfilling, increased sensitivity of the bladder, and urinary tract infections.